BridgeBio Pharma grants 57,853 restricted stock units to 32 new employees

By Public Technologies
  • BridgeBio Pharma approved restricted stock units covering 57,853 common shares for 32 new employees on October 14, 2026.
  • Each award will vest 25% on November 16, 2027, followed by quarterly vesting of one-twelfth of the remaining shares.
  • Vesting is subject to continued employment with the company or one of its subsidiaries on each vesting date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BridgeBio Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610160730PRIMZONEFULLFEED9846824) on October 16, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk